Monsanto Company (MON) Position Reduced by Russell Investments Group Ltd.

Russell Investments Group Ltd. reduced its stake in Monsanto Company (NYSE:MON) by 5.9% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 430,517 shares of the basic materials company’s stock after selling 27,042 shares during the period. Russell Investments Group Ltd. owned approximately 0.10% of Monsanto worth $51,574,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Pinnacle Financial Partners Inc. acquired a new stake in shares of Monsanto in the second quarter valued at $114,000. Bruderman Asset Management LLC purchased a new position in Monsanto in the second quarter valued at $116,000. Tower Research Capital LLC TRC increased its holdings in Monsanto by 230.1% in the second quarter. Tower Research Capital LLC TRC now owns 1,076 shares of the basic materials company’s stock valued at $128,000 after buying an additional 750 shares during the last quarter. Armbruster Capital Management Inc. increased its holdings in Monsanto by 12.2% in the second quarter. Armbruster Capital Management Inc. now owns 1,147 shares of the basic materials company’s stock valued at $136,000 after buying an additional 125 shares during the last quarter. Finally, Enterprise Financial Services Corp increased its holdings in Monsanto by 1.2% in the second quarter. Enterprise Financial Services Corp now owns 1,384 shares of the basic materials company’s stock valued at $164,000 after buying an additional 16 shares during the last quarter. Institutional investors and hedge funds own 75.70% of the company’s stock.

In other news, VP Duraiswami Narain sold 2,860 shares of the stock in a transaction dated Monday, September 25th. The shares were sold at an average price of $120.00, for a total transaction of $343,200.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Pierre Courduroux sold 4,320 shares of the stock in a transaction dated Thursday, October 19th. The stock was sold at an average price of $122.00, for a total transaction of $527,040.00. Following the sale, the chief financial officer now owns 48,388 shares of the company’s stock, valued at approximately $5,903,336. The disclosure for this sale can be found here. Insiders have sold 49,236 shares of company stock valued at $5,931,934 in the last quarter. Insiders own 0.79% of the company’s stock.

Several equities analysts recently commented on MON shares. Zacks Investment Research lowered Monsanto from a “buy” rating to a “hold” rating in a report on Tuesday, September 12th. Wells Fargo & Company increased their target price on Monsanto from $107.50 to $118.00 and gave the company a “market perform” rating in a report on Tuesday, October 10th. UBS lowered Monsanto from a “buy” rating to a “neutral” rating and set a $128.00 target price on the stock. in a report on Friday, August 18th. BidaskClub raised Monsanto from a “sell” rating to a “hold” rating in a report on Saturday, August 19th. Finally, Barclays reissued an “equal weight” rating and issued a $124.00 target price (up previously from $120.00) on shares of Monsanto in a report on Thursday, October 5th. Eleven analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. Monsanto presently has a consensus rating of “Hold” and an average target price of $124.61.

Shares of Monsanto Company (NYSE:MON) traded down $0.32 during mid-day trading on Monday, hitting $118.61. The company’s stock had a trading volume of 2,152,256 shares, compared to its average volume of 1,962,155. The stock has a market capitalization of $52,352.99, a price-to-earnings ratio of 21.51, a price-to-earnings-growth ratio of 1.71 and a beta of 1.04. Monsanto Company has a 12 month low of $104.05 and a 12 month high of $122.79. The company has a debt-to-equity ratio of 1.12, a quick ratio of 0.83 and a current ratio of 1.35.

Monsanto (NYSE:MON) last issued its quarterly earnings data on Wednesday, October 4th. The basic materials company reported $0.20 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.41) by $0.61. The company had revenue of $2.69 billion for the quarter, compared to analyst estimates of $2.51 billion. Monsanto had a return on equity of 42.40% and a net margin of 15.44%. The business’s quarterly revenue was up 4.8% compared to the same quarter last year. During the same quarter last year, the company posted $0.07 earnings per share. research analysts forecast that Monsanto Company will post 5.74 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 26th. Shareholders of record on Friday, January 5th will be issued a dividend of $0.54 per share. This represents a $2.16 annualized dividend and a dividend yield of 1.82%. Monsanto’s payout ratio is 42.27%.

TRADEMARK VIOLATION WARNING: This report was originally reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this report on another website, it was copied illegally and republished in violation of United States & international trademark & copyright legislation. The original version of this report can be viewed at https://www.dispatchtribunal.com/2017/12/04/russell-investments-group-ltd-has-51-57-million-stake-in-monsanto-company-mon.html.

Monsanto Company Profile

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

Institutional Ownership by Quarter for Monsanto (NYSE:MON)

Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply